Refractory Behçet's disease succesfully treated with Roflumilast.
Clinical and experimental dermatology(2023)
Abstract
We report the first case of refractory Behçet disease with spectacular response to roflumilast 250 μg per day and no notable adverse effects beyond a self-resolving headache.
MoreTranslated text
Key words
behçet,disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined